Krane
Elliot Krane, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20140364798 | Indwelling Nerve Block Catheters - A nerve block catheter system employs an indwelling, flexible catheter comprising a tissue lock to retain the catheter tip in pharmacologically proximity to a target nerve and optionally, a decoupler that insulates the tip of the catheter from proximal tissue movement. | 12-11-2014 |
Elliot Krane, Stanford, CA US
Patent application number | Description | Published |
---|---|---|
20110218529 | Indwelling Nerve Block Catheters - A nerve block catheter system employs an indwelling, flexible catheter comprising a tissue lock to retain the catheter tip in pharmacologically proximity to a target nerve and optionally, a decoupler that insulates the tip of the catheter from proximal tissue movement. | 09-08-2011 |
Florian V. Krane, Kirchberg/murr DE
Patent application number | Description | Published |
---|---|---|
20090194057 | Starter Apparatus for an internal combustion engine - A starter device for an internal combustion engine ( | 08-06-2009 |
Ian Krane, Westborough, MA US
Patent application number | Description | Published |
---|---|---|
20090246194 | ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINS - Erythropoietin analog-human IgG fusion protein (EPOa-IgG) fusion protein and methods of making and using the fusion protein. | 10-01-2009 |
Rolf Krane, Wiesloch DE
Patent application number | Description | Published |
---|---|---|
20100162147 | UI-DRIVEN BINDING OF EXTENSION FIELDS TO BUSINESS OBJECTS - A system may include presentation of a user interface including fields associated with a business object, reception, via the user interface, of an instruction to add an extension field to the business object, reception, via the user interface, of an indication of a reference field of the business object, determination of a binding of the reference field to the business object, and binding of the extension field to the business object based on the determined binding of the reference field to the business object. | 06-24-2010 |
20120023484 | AUTOMATION OF TESTING FOR USER INTERFACE APPLICATIONS - A host software application implementing business processes and providing a graphical display associated with a user interface (UI) for a user in a client program executing on a client frontend device that is separate from a backend device storing metadata associated with the UI may be initiated. An automation graphical symbol may provide the user with an option to initiate a test on events of the host software application, during execution of the host software application. A request from the user may be received, to initiate a test on events of the host software application. Information may be received from the user indicating one or more selected specific events for performing the test. The test may be initiated on the selected specific events, based on a state of execution of the host software application at an initial time of the user indicating the selected specific events for performing the test. | 01-26-2012 |
20130268834 | CREATING INTERACTIVE FORMS FROM APPLICATIONS' USER INTERFACE - In one aspect, an interactive form container is generated for creation of an interactive form based on a UI of an application. The interactive form container establishes communication with the UI of the application. A data is received indicative of interactions with the UI of the application to execute a task associated with the application. Based on the interactions, a script records the interactions with the UI. In another aspect, copied UI objects from the UI of the application are added to the interactive form container to create the UI of the interactive form. The UI of the interactive form in association with the recorded script are stored to create the interactive form. | 10-10-2013 |
Rolf Krane, Weisloch DE
Patent application number | Description | Published |
---|---|---|
20140173478 | SIZE ADJUSTMENT CONTROL FOR USER INTERFACE ELEMENTS - A knob element associated with a user interface element in a graphical user interface can be translated in response to a rotational user input motion. As the knob element is translated around the user interface element, a change in the size of the user interface element can occur that is at least in part based on amount of rotational distance. | 06-19-2014 |
20140173480 | SELECTOR CONTROL FOR USER INTERFACE ELEMENTS - A user input at a location on a user interface screen that intersects or otherwise touches a grouping of more than one overlapping user interface element can enable selection of a specific one of the overlapping user interface elements as the user interface elements in the grouping are made active in sequence (e.g. in a loop), which can be stopped by a second user input when the desired user interface element is currently active in the sequence. Related methods, system, article of manufacture, and the like are also disclosed. | 06-19-2014 |
Sonja Krane, Del Mar, CA US
Patent application number | Description | Published |
---|---|---|
20090156668 | Ginkgolide Compounds, Compositions, And Extracts, And Uses Thereof - The present invention relates to Ginkgolide derivatives, compositions and extracts comprising one or more Ginkgolides and/or derivatives thereof and methods of use of the compositions to treat neurological disorders and as imaging agents. | 06-18-2009 |
Stephen Krane, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20130287688 | NOVEL COMPOSITIONS AND USES OF ANTI-HYPERTENSION AGENTS FOR CANCER THERAPY - Methods and compositions for improving the delivery and/or efficacy of a therapy (e.g., a cancer therapy) are disclosed. In one embodiment, methods and compositions for treating or preventing a cancer (e.g., a solid tumor such as a desmoplastic tumor) by administering to a subject an anti-hypertensive agent, as a single agent or in combination with a microenvironment modulator and/or a therapy, e.g., a cancer therapy (for example, a therapeutic agent or therapy, including immunotherapy (e.g., antibodies, vaccine, cell-based), nanotherapeutics, radiation therapy, photodynamic therapy, low molecular weight chemotherapeutics, molecularly targeted therapeutics and/or oxygen radical) are disclosed. | 10-31-2013 |
Uwe Krane, Berlin DE
Patent application number | Description | Published |
---|---|---|
20100194893 | Process For Monitoring Territories In Order To Recognise Forest And Surface Fires - The monitoring of territories in order to recognize forest and surface fires requires complex automatic and human-assisted processes, which ultimately must include the control of intervention forces. Disclosed are processes for the centralised monitoring of territories. A swiveling and tiltable camera installed at a monitoring site supplies images of overlapping observation sectors. In each observation sector a sequence of images comprising a plurality of images is taken, at an interval which corresponds to fire and smoke dynamics. An on-site image-processing software supplies event warnings with indication of the position of the event site in the analysed image. A total image and an image sequence with image sections of the vent site are then transmitted to a central station and reproduced at the central station as an endless sequence in quick-motion mode. Event warnings with all relevant data can be blended into electronic maps at the central station. Cross-bearing is made possible by blending event warnings from adjacent monitoring sites. False alarms are minimized in that known false alarm sources are marked as exclusion zones in reference images. | 08-05-2010 |
Vera Krane, Wurzburg AT
Patent application number | Description | Published |
---|---|---|
20130143240 | HOMOARGININE AS A BIOMARKER FOR THE RISK OF MORTALITY - The present invention relates to the field of laboratory diagnostics. Specifically, means and methods for determining the risk of mortality in a patient based on homoarginine and to reduce the risk of mortality by administration of homoarginine are disclosed. Moreover, the present invention relates to the use of homoarginine for the preparation of a medicament for the treatment of a patient having an increased risk of mortality caused by stroke or a cardiac cause. Furthermore, the present application relates to a pharmaceutical composition comprising homoarginine and a composition for foodstuff supplement comprising homoarginine. | 06-06-2013 |